Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06634355
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-07
Brief Title:
Placental Transfer of Sugammadex in the Human Placental Perfusion Model
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Placental Transfer of Sugammadex in the Human Placental Perfusion Model
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Preclinical research raised concern regarding the foetal effects of using sugammadex during pregnancy However to the best of our knowledge the placental transfer of sugammadex has never been measured As these data would be critical in assessing the foetal effects after maternal administration of sugammadex it is warranted to measure the placental transfer of sugammadex The aim of this project is to measure the placental transfer of sugammadex in the human placenta by using the ex vivo human placenta perfusion model
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None